Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks .

Recent Articles

Google Still Looks Attractive Given an Expected Rise in Ad Sales

By Mark R. Hake, CFA Jan 5, 2021

Google still looks attractive given an expected rise in ad sales in 2021. Google stock is worth at least 20.3% more at $2,112 given a price-to-sales comparison with Apple, Amazon, and Microsoft.

Luckin Coffee Now Has a Chance of a Turnaround and Redemption

By Mark R. Hake, CFA Jan 5, 2021

With a new chance of a turnaround and redemption, Luckin stock could be worth between 41% and 86% above today's price. Read here about what the liquidators' report implies.

XPEV Is Worth Far More Than Its Present Price

By Mark R. Hake, CFA Dec 31, 2020

XPeng is worth far more than its present price. XPEV stock is worth 31% to 100% more based on the growth in the Chinese EV market.

Plug Power Is Overly Hyped With No Prospects of Profits

By Mark R. Hake, CFA Dec 31, 2020

Plug Power is another overly hyped stock with no profits. Plug stock is up almost 10x with no chance of profits for the next two years.

Moderna Stock Is Worth Much More

By Mark R. Hake, CFA Dec 31, 2020

Moderna reaps the rewards of its Covid-19 vaccine, and MRNA stock is worth 57% to 172% more based on near-term and long-term earnings power.